Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.

Avirović M, Matušan-Ilijaš K, Damante G, Fabrro D, Cerović R, Juretić M, Grahovac B, Jonjić N, Lučin K.

J Oral Pathol Med. 2013 Sep;42(8):620-6. doi: 10.1111/jop.12055. Epub 2013 Feb 25.

PMID:
23438150
2.

The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.

Chiu YW, Tu HF, Wang IK, Wu CH, Chang KW, Liu TY, Kao SY.

Oral Oncol. 2010 Apr;46(4):302-6. doi: 10.1016/j.oraloncology.2010.01.018. Epub 2010 Mar 9.

PMID:
20219412
3.

Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma.

Chien CY, Su CY, Chuang HC, Fang FM, Huang HY, Chen CH, Chen CM, Huang CC.

Oral Oncol. 2009 Sep;45(9):798-802. doi: 10.1016/j.oraloncology.2008.12.006. Epub 2009 Feb 11.

PMID:
19213594
4.

[Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].

Lu XZ, Yin XM, Feng YY, Duan LQ, Chen WT, Zhang CP.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jul;28(7):1165-7. Chinese.

5.

Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.

Klimowicz AC, Bose P, Nakoneshny SC, Dean M, Huang L, Chandarana S, Magliocco AM, Wayne Matthews T, Brockton NT, Dort JC.

Eur J Cancer. 2012 Sep;48(14):2166-74. doi: 10.1016/j.ejca.2012.04.010. Epub 2012 Aug 12.

PMID:
22892062
6.

Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.

Chen YS, Wang JT, Chang YF, Liu BY, Wang YP, Sun A, Chiang CP.

J Oral Pathol Med. 2004 Apr;33(4):209-17.

PMID:
15061708
7.

Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.

Ogbureke KU, Nikitakis NG, Warburton G, Ord RA, Sauk JJ, Waller JL, Fisher LW.

Oral Oncol. 2007 Oct;43(9):920-32. Epub 2007 Feb 15.

PMID:
17306612
8.

Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.

Fujii N, Shomori K, Shiomi T, Nakabayashi M, Takeda C, Ryoke K, Ito H.

J Oral Pathol Med. 2012 Jul;41(6):444-51. doi: 10.1111/j.1600-0714.2012.01127.x. Epub 2012 Feb 2.

PMID:
22296275
9.

Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.

Matusan K, Dordevic G, Stipic D, Mozetic V, Lucin K.

J Surg Oncol. 2006 Sep 15;94(4):325-31.

PMID:
16917865
10.

Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma.

Pappa E, Nikitakis N, Vlachodimitropoulos D, Avgoustidis D, Oktseloglou V, Papadogeorgakis N.

J Oral Maxillofac Surg. 2014 Jan;72(1):211-21. doi: 10.1016/j.joms.2013.06.198. Epub 2013 Aug 29.

PMID:
23992782
11.

[The expression and significance of osteopontin and its receptor CD44v6 in oral squamous carcinoma].

Jiang L, Zhao LY, He J, Zhao YF, Wu Y, Liu Y, Jiang XZ.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2008 Jun;26(3):248-51. Chinese.

12.

Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.

Lin CY, Chen ST, Jeng YM, Yeh CC, Chou HY, Deng YT, Chang CC, Kuo MY.

J Oral Pathol Med. 2011 Oct;40(9):699-705. doi: 10.1111/j.1600-0714.2011.01019.x. Epub 2011 Feb 25.

PMID:
23647076
13.

Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.

Wei Z, Wang Y, Li Z, Yuan C, Zhang W, Wang D, Ye J, Jiang H, Wu Y, Cheng J.

J Oral Pathol Med. 2013 Nov;42(10):747-54. doi: 10.1111/jop.12062. Epub 2013 Mar 29.

PMID:
23551691
14.

Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.

Montebugnoli L, Gissi DB, Badiali G, Marchetti C, Cervellati F, Farnedi A, Foschini MP.

J Oral Maxillofac Surg. 2011 Oct;69(10):2579-84. doi: 10.1016/j.joms.2010.10.041. Epub 2011 Feb 3.

PMID:
21292374
15.

Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.

Routray S, Kheur SM, Kheur M.

Ann Diagn Pathol. 2013 Oct;17(5):421-4. doi: 10.1016/j.anndiagpath.2013.03.005. Epub 2013 May 24.

PMID:
23711950
16.

High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.

Pukkila M, Kosunen A, Ropponen K, Virtaniemi J, Kellokoski J, Kumpulainen E, Pirinen R, Nuutinen J, Johansson R, Kosma VM.

J Clin Pathol. 2007 Mar;60(3):267-72. Epub 2006 May 26.

17.

EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology.

Monteiro LS, Diniz-Freitas M, Garcia-Caballero T, Forteza J, Fraga M.

J Oral Pathol Med. 2010 Aug 1;39(7):571-8. doi: 10.1111/j.1600-0714.2009.00876.x. Epub 2010 Feb 14.

PMID:
20202087
18.

Midkine expression in oral squamous cell carcinoma and leukoplakia.

Jham BC, Costa NL, Silva JM, de Miranda AC, Oliveira JC, Silva TA, Batista AC.

J Oral Pathol Med. 2012 Jan;41(1):21-6. doi: 10.1111/j.1600-0714.2011.01049.x. Epub 2011 May 20.

PMID:
21595751
19.

Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R, Winstanley JH, Howitt R, West CR.

Cancer Res. 2002 Jun 15;62(12):3417-27.

20.

Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.

Ahmed Haji Omar A, Haglund C, Virolainen S, Häyry V, Atula T, Kontio R, Rihtniemi J, Pihakari A, Salo T, Hagström J, Sorsa T.

J Oral Pathol Med. 2013 May;42(5):389-95. doi: 10.1111/jop.12025. Epub 2012 Dec 21.

PMID:
23278563

Supplemental Content

Support Center